Evidence map›Paper›PMID 27098265›Full record

ArticleInternational journal of cancer2016

Record linkage to correct under-ascertainment of cancers in HIV cohorts: The Sinikithemba HIV clinic linkage project.

Mazvita Sengayi, Adrian Spoerri, Matthias Egger, Danuta Kielkowski, Tamaryn Crankshaw, Christie Cloete, Janet Giddy, Julia Bohlius

Abstract read
In one paragraph

Article in International journal of cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Observational
  11. Observational
  12. Article
  13. Brief Report: Malignancies in Adults Living With HIV in Asia.Journal of acquired immune deficiency syndromes (1999) · 2019
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mazvita SengayiNational Cancer Registry, National Health Laboratory Service, Johannesburg, South Africa.ORCID 0000-0002-1955-923X
Adrian SpoerriInstitute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
Matthias EggerInstitute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
Danuta KielkowskiNational Cancer Registry, National Health Laboratory Service, Johannesburg, South Africa.
Tamaryn CrankshawHealth Economics HIV And AIDS Research Division (HEARD), University of KwaZulu-Natal, Durban, South Africa.
Christie CloeteMcCord Hospital, Overport, Durban, South Africa.
Janet GiddyMcCord Hospital, Overport, Durban, South Africa.
Julia BohliusInstitute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.

Funding

Observational Antiretroviral Studies In Southern Africa (OASIS) CollaborationU01AI069924 · NIAID · UNIVERSITAT BERN · PI Cleophas Chimbetete, Mary-Ann Davies · 2006 to 2026
$55.9M
NIAID NIH HHS U01 AI069924
6 · The paper itself

Abstract

The surveillance of HIV-related cancers in South Africa is hampered by the lack of systematic collection of cancer diagnoses in HIV cohorts and the absence of HIV status in cancer registries. To improve cancer ascertainment and estimate cancer incidence, we linked records of adults (aged ≥ 16 years) on antiretroviral treatment (ART) enrolled at Sinikithemba HIV clinic, McCord Hospital in KwaZulu-Natal (KZN) with the cancer records of public laboratories in KZN province using probabilistic record linkage (PRL) methods. We calculated incidence rates for all cancers, Kaposi sarcoma (KS), cervix, non-Hodgkin's lymphoma and non-AIDS defining cancers (NADCs) before and after inclusion of linkage-identified cancers with 95% confidence intervals (CIs). A total of 8,721 records of HIV-positive patients were linked with 35,536 cancer records. Between 2004 and 2010, we identified 448 cancers, 82% (n = 367) were recorded in the cancer registry only, 10% (n = 43) in the HIV cohort only and 8% (n = 38) both in the HIV cohort and the cancer registry. The overall cancer incidence rate in patients starting ART increased from 134 (95% CI 91-212) to 877 (95% CI 744-1,041) per 100,000 person-years after inclusion of linkage-identified cancers. Incidence rates were highest for KS (432, 95% CI 341-555), followed by cervix (259, 95% CI 179-390) and NADCs (294, 95% CI 223-395) per 100,000 person-years. Ascertainment of cancer in HIV cohorts is incomplete, PRL is both feasible and essential for cancer ascertainment.

Indexed as

Models, StatisticalAdolescentAdultAgedAntiretroviral Therapy, Highly ActiveDatasets as TopicFemaleHIV InfectionsHumansIncidenceMaleMiddle AgedNeoplasmsPopulation SurveillancePrevalenceProportional Hazards ModelscancerHIVrecord linkageSouth Africa

Identifiers

PMID27098265
PMCPMC5084785

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.